Copenhagen, Denmark

Henrik Ravn Aage

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Takeda as, Takeda Nycomed as. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Ravn Aage. Retrieved from https://idiyas.com/inventor/henrik-ravn-aage

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Henrik Ravn Aage

Introduction

Henrik Ravn Aage is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of calcium carbonate tablets. With a total of 2 patents, Aage's work reflects his dedication to enhancing medication efficacy.

Latest Patents

One of his latest patents focuses on the dissolution stability of calcium carbonate tablets. This invention relates to a method for the preparation of a tablet comprising at least 50% w/w of calcium carbonate. The method aims to improve the stability and effectiveness of these tablets, ensuring better patient outcomes.

Career Highlights

Throughout his career, Henrik Ravn Aage has worked with prominent companies in the pharmaceutical industry, including Takeda Nycomed A/S and Takeda A/S. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in medication formulation.

Collaborations

Aage has collaborated with several professionals in his field, including Peder Mohr Olsen and Poul Bertelsen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.

Conclusion

Henrik Ravn Aage's contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to innovation. His work continues to influence the development of effective medication solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…